The AURORA molecular screening programme for metastatic breast cancer

URORA is an academia-driven initiative that aims to boost genomic and clinical knowledge generated from metastatic breast cancer patients. It is expected that detailed molecular profiling of breast cancer makes deeper current understanding of the molecular biology underpinning this common disease, promising to lead to personalised cancer medicine, according to description of the programme goals and study plan in an article published by Dr Dimitrios Zardavas and colleagues in the British Journal of Cancer. Read more here.